Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2015

Nov 2, 2015

30718_dirs_2015-11-02_cd391ba2-8186-480a-8cb6-37edffbe5f8e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2015-10-29

Reporting Person: LUCAS ROGER C (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-10-29 Common Stock A 1059.00 $0.00 Acquired 4515.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-10-29 Stock Option (Right to Buy) $87.34 A 4260.00 Acquired 2025-10-28 Common Stock (4260.00) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $87.39 2023-10-30 Common Stock (4000.00) 4000.00 Direct
Stock Option (right to buy) $70.35 2021-10-26 Common Stock (5000.00) 5000.00 Direct
Stock Options (Right to buy) $91.78 2024-10-30 Common Stock (4000.00) 4000.00 Direct
Stock Options (Right to buy) $66.90 2022-10-24 Common Stock (5000.00) 5000.00 Direct